Form 4: Veracyte Director Jens Holstein Sells 5,000 Shares Under 10b5-1 Plan
SEC Form 4
Director Jens Holstein sold 5,000 shares of Veracyte (VCYT) common stock on July 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 16, 2024, Jens Holstein, a director of Veracyte, Inc. (VCYT), sold 5,000 shares of common stock.
- The sales were executed in two transactions at prices of $24 and $25 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2024.
- Following the reported transactions, Holstein directly owns 32,878 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document is a standard Form 4 filing, indicating a routine stock sale under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales by insiders are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date the reporting person adopted a Rule 10b5-1 plan |
| 07/16/2024 | Date of the stock sale transactions |
| 07/18/2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.